Loading, Please Wait...

CST: 25/06/2019 20:41:40   

Global Over The Counter/OTC Test Market 2018-2019 & 2024: Leading Players Focus on Organic and Inorganic Growth Strategies

71 Days ago

Dublin, April 15, 2019 (GLOBE NEWSWIRE) -- The "Over The Counter/OTC Test Market by Product and Technology - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period.

The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.

In this report, the OTC tests market is categorized based on product, technology, and region. The key players operating in the OTC tests market are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).

A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the OTC tests market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Growing Prevalence of Diabetes High Prevalence of Infectious Diseases in Developing Countries Growing Support and Collaboration for Developing OTC Tests
5.2.2 Opportunities Introduction of Combined Kits for Testing Pregnancy and Ovulation
5.2.3 Challenges Invasiveness of Blood Glucose Monitors and Cholesterol Monitors

6 Over the Counter Tests Market, By Technology
6.1 Introduction
6.2 Lateral Flow Assays
6.2.1 Lateral Flow Assays to Register the Highest Growth During the Forecast Period
6.3 Immunoassays
6.3.1 Increasing Use of Immunoassays for Pregnancy & Infectious Disease Testing is Driving Market Growth
6.4 Dipsticks
6.4.1 Dipsticks Provide Only A Qualitative Analysis, Which is A Major Factor Restraining Market Growth

7 Over the Counter Tests Market, By Product
7.1 Introduction
7.2 Glucose Monitoring Tests
7.2.1 Glucose Monitoring Tests Dominated the OTC Tests Market in 2018
7.3 Pregnancy & Fertility Tests
7.3.1 Advantages of Pregnancy & Fertility Tests Have Driven Companies to Focus on Product Development
7.4 Infectious Disease Tests
7.4.1 Increasing Prevalence of Infectious Diseases is Driving Market Growth
7.5 Coagulation Monitoring Tests
7.5.1 Coagulation Monitoring Tests Provide Quick and Reliable Results
7.6 Urinalysis Tests
7.6.1 Increasing Prevalence of Urinary Tract Infections is A Major Factor Driving Market Growth
7.7 Cholesterol Tests
7.7.1 Convenience of Home-Use Tests has Expanded their Use
7.8 Drugs-Of-Abuse Tests
7.8.1 Rising Production and Consumption of Illegal Drugs Have Driven the Focus on Testing
7.9 Other Tests

8 Over the Counter Tests Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US US to Dominate The North America OTC Tests Market
8.2.2 Canada Increasing Government Initiatives to Support the Adoption of POC Products to Drive Market Growth in Canada
8.3 Europe
8.3.1 Germany Germany is the Fastest-Growing Market in Europe
8.3.2 France High Demand for Glucose Testing Kits to Drive Market Growth in France
8.3.3 UK Increasing Awareness of Oct Tests Among the Users
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Asia Pacific is the Fastest-Growing Segment of the Global OTC Tests Market
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Vendor Benchmarking
9.3 Competitive Leadership Mapping
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Dynamic Differentiators
9.3.4 Emerging Companies
9.4 Market Ranking Analysis, 2017
9.5 Competitive Situation and Trends
9.5.1 Product Launches
9.5.2 Collaborations, Partnerships, and Agreements
9.5.3 Acquisitions

10 Company Profiles
10.1 Roche Diagnostics
10.2 Abbott Laboratories
10.3 Orasure Technologies
10.4 Accubiotech
10.5 LIA Diagnostics
10.6 Labstyle Innovations
10.7 SD Biosensor
10.8 Acon Laboratories Inc
10.9 Sinocare
10.10 Nowdiagnostics Company
10.11 iHealth Lab
10.12 Biolytical Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/vuonak

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs

Is your business listed correctly on America’s largest city directory network of 1,000 portals?